Life Sciences Regulatory Expert Aman Khera Joins emTRUTH Healthcare Advisory Board
emTRUTH, whose mission is to help healthcare companies unlock the full value of their data, today announced the addition of Worldwide Clinical Trials Global Head of Regulatory Strategy, Aman Khera, to the Company’s Healthcare Advisory Board.
An innovative drug and device development leader, Khera joins the emTRUTH Healthcare Advisory Board on the heels of her appointment to the PharmaVOICE 100 as one of the most influential and inspiring people in the life sciences industry.
With a focus on enabling secure and easy access to healthcare data, from anywhere, in any standard or size, the emTRUTH Healthcare Advisory Board is comprised of leaders and clinicians who represent the provider, payer, pharmaceutical, medical device, and healthcare technology sectors. Khera adds more than two decades of experience in providing strategic direction in regulatory affairs to biotech, pharmaceutical, contract research organizations (CROs), and life sciences investors.
“Aman is an invaluable asset to emTRUTH’s Healthcare Advisory Board,” said Irene Woerner, CEO, emTRUTH. “From her perspective on how regulations, ethics, and compliance interplay, to her focus on how innovations, like blockchain and AI, can transform life sciences, Aman’s impressive insight will help us in our mission to help healthcare companies unlock the full value of their data.”
Khera is known by many as the ‘Rebel Regulator’ for her track record in anticipating and addressing inevitable regulatory challenges in the drug development process. Her insight has changed the way people think about regulatory processes and has resulted in fewer late-stage surprises, smoother trials, and optimal outcomes for the development of new therapies.
“I am honored to join this esteemed team of experienced leaders with impressive track records in healthcare, AI and blockchain,” said Khera. “I share their passion for helping emTRUTH in their innovative approach towards simplifying the process of combining and sharing data ethically, and I am thrilled at the breakthrough opportunities this will open up for healthcare and life sciences.”
In addition to her work with emTRUTH and Worldwide Clinical Trials, Khera volunteers her time with organizations such as DIA, The Organization for Professionals in Regulatory Affairs (TOPRA) and the Regulatory Affairs Professionals Society (RAPS). She holds a Bachelor of Science in Medical Biochemistry from Brunel University, London, UK and is currently working towards an Executive MBA.
emTRUTH unlocks the power of healthcare data. We do this by making it quick and easy for healthcare users (who are not IT experts) to securely combine and share data on demand, while they, and their patients, retain full ownership and control of their data. The company’s patent-pending technology offers fast and secure horizontal or vertical data integration and interoperability of any type of data. With one API. From anywhere. Using any standard. To any app. In days, not months. For less. For more information, visit www.emtruth.com.